130 related articles for article (PubMed ID: 9354198)
1. Effect of omeprazole on the bioavailability of unmodified and phospholipid-complexed aspirin in rats.
Giraud MN; Sanduja SK; Felder TB; Illich PA; Dial EJ; Lichtenberger LM
Aliment Pharmacol Ther; 1997 Oct; 11(5):899-906. PubMed ID: 9354198
[TBL] [Abstract][Full Text] [Related]
2. Nonsteroidal anti-inflammatory drug and phospholipid prodrugs: combination therapy with antisecretory agents in rats.
Lichtenberger LM; Ulloa C; Romero JJ; Vanous AL; Illich PA; Dial EJ
Gastroenterology; 1996 Oct; 111(4):990-5. PubMed ID: 8831593
[TBL] [Abstract][Full Text] [Related]
3. Antisecretory and antiulcer effect of T-330, a novel reversible proton pump inhibitor, in rats.
Kinoshita M; Saito N; Tamaki H
Eur J Pharmacol; 1997 Mar; 321(3):325-32. PubMed ID: 9085044
[TBL] [Abstract][Full Text] [Related]
4. Bioavailability of aspirin in rats comparing the drug's uptake into gastrointestinal tissue and vascular and lymphatic systems: implications on aspirin's chemopreventive action.
Lichtenberger LM; Phan T; Fang D; Edler S; Philip J; Li-Geng T; Dial EJ
J Physiol Pharmacol; 2016 Oct; 67(5):635-642. PubMed ID: 28011944
[TBL] [Abstract][Full Text] [Related]
5. Effect of vitamin E supplementation on prostaglandin concentrations in aspirin-induced acute gastric injury in aged rats.
Stickel F; Meydani M; Wu D; Bronson R; Martin A; Smith D; Meydani SN; Russell RM
Am J Clin Nutr; 1997 Nov; 66(5):1218-23. PubMed ID: 9356541
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of protection by pantoprazole against NSAID-induced gastric mucosal damage.
Fornai M; Natale G; Colucci R; Tuccori M; Carazzina G; Antonioli L; Baldi S; Lubrano V; Abramo A; Blandizzi C; Del Tacca M
Naunyn Schmiedebergs Arch Pharmacol; 2005 Jul; 372(1):79-87. PubMed ID: 16080005
[TBL] [Abstract][Full Text] [Related]
7. Induction of tumor necrosis factor-alpha and apoptosis in gastric mucosal injury by indomethacin: effect of omeprazole and ebrotidine.
Slomiany BL; Piotrowski J; Slomiany A
Scand J Gastroenterol; 1997 Jul; 32(7):638-42. PubMed ID: 9246701
[TBL] [Abstract][Full Text] [Related]
8. Intragastric acidity and omeprazole exposure during dosing with either PA32540 (enteric-coated aspirin 325 mg + immediate-release omeprazole 40 mg) or enteric-coated aspirin 325 mg + enteric-coated omeprazole 40 mg - a randomised, phase 1, crossover study.
Miner PB; Fort JG; Zhang Y
Aliment Pharmacol Ther; 2013 Jul; 38(1):62-71. PubMed ID: 23692061
[TBL] [Abstract][Full Text] [Related]
9. Effects of IY-81149, a newly developed proton pump inhibitor, on gastric acid secretion in vitro and in vivo.
Kwon D; Chae JB; Park CW; Kim YS; Lee SM; Kim EJ; Huh IH; Kim DY; Cho KD
Arzneimittelforschung; 2001; 51(3):204-13. PubMed ID: 11304936
[TBL] [Abstract][Full Text] [Related]
10. Effects of non-steroidal anti-inflammatory drugs on rat gastric mucosal leukotriene C4 and prostanoid release: relation to ethanol-induced injury.
Peskar BM; Hoppe U; Lange K; Peskar BA
Br J Pharmacol; 1988 Apr; 93(4):937-43. PubMed ID: 3390662
[TBL] [Abstract][Full Text] [Related]
11. Phospholipid association reduces the gastric mucosal toxicity of aspirin in human subjects.
Anand BS; Romero JJ; Sanduja SK; Lichtenberger LM
Am J Gastroenterol; 1999 Jul; 94(7):1818-22. PubMed ID: 10406241
[TBL] [Abstract][Full Text] [Related]
12. The long-lasting effect of TU-199, a novel H+, K(+)-ATPase inhibitor, on gastric acid secretion in dogs.
Uchiyama K; Wakatsuki D; Kakinoki B; Takeuchi Y; Araki T; Morinaka Y
J Pharm Pharmacol; 1999 Apr; 51(4):457-64. PubMed ID: 10385219
[TBL] [Abstract][Full Text] [Related]
13. [Warm-needle moxibustion therapy may reduce aspirin-induced gastric mucosal injury in rats].
Sun SL; Sun ZR; Liu M; Li CM; He W; Gao T; Liu M
Zhen Ci Yan Jiu; 2011 Feb; 36(1):28-31. PubMed ID: 21585055
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic interaction between proton pump inhibitors and roxithromycin in volunteers.
Kees F; Holstege A; Ittner KP; Zimmermann M; Lock G; Schölmerich J; Grobecker H
Aliment Pharmacol Ther; 2000 Apr; 14(4):407-12. PubMed ID: 10759619
[TBL] [Abstract][Full Text] [Related]
15. Biochemical and pharmacological properties of a newly synthesized proton pump (H+/K(+)-ATPase) inhibitor, TY-11345 in experimental animals.
Yamaguchi T; Aihara K; Yamada S; Narita S; Kogi K
Jpn J Pharmacol; 1993 Aug; 62(4):363-71. PubMed ID: 8230863
[TBL] [Abstract][Full Text] [Related]
16. Lansoprazole prevents experimental gastric injury induced by non-steroidal anti-inflammatory drugs through a reduction of mucosal oxidative damage.
Blandizzi C; Fornai M; Colucci R; Natale G; Lubrano V; Vassalle C; Antonioli L; Lazzeri G; Del Tacca M
World J Gastroenterol; 2005 Jul; 11(26):4052-60. PubMed ID: 15996031
[TBL] [Abstract][Full Text] [Related]
17. Zwitterionic phospholipids enhance aspirin's therapeutic activity, as demonstrated in rodent model systems.
Lichtenberger LM; Ulloa C; Vanous AL; Romero JJ; Dial EJ; Illich PA; Walters ET
J Pharmacol Exp Ther; 1996 Jun; 277(3):1221-7. PubMed ID: 8667182
[TBL] [Abstract][Full Text] [Related]
18. Omeprazole prevents indomethacin-induced gastric ulcers in rabbits.
Lee M; Kallal SM; Feldman M
Aliment Pharmacol Ther; 1996 Aug; 10(4):571-6. PubMed ID: 8853761
[TBL] [Abstract][Full Text] [Related]
19. Effects of different antisecretory drugs on gastric potential difference in the rat: comparison with sucralfate.
Coruzzi G; Coppelli G; Frati P; Bertaccini G
Pharmacol Res; 1998 Dec; 38(6):469-73. PubMed ID: 9990656
[TBL] [Abstract][Full Text] [Related]
20. A subchronic study of the effect of etodolac on the gastric mucosal prostaglandin levels in the rat.
Lee DK; Cohen R; Gilliar J; Mulder B; Smith T
Agents Actions; 1986 Nov; 19(3-4):228-32. PubMed ID: 2950733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
